JEREMY KORTEWEG: Open Payments
NPI 1073801015 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 31 payments from 12 companies in 2025. Trend: 2023 $882 · 2024 $540 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $147 |
| Dexcom, Inc. | 2 | $96 |
| Novo Nordisk Inc | 4 | $84 |
| SANOFI-AVENTIS U.S. LLC | 3 | $81 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
| PFIZER INC. | 2 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 2 | $32 |
| Tris Pharma Inc | 1 | $19 |
Products named: UBRELVY, DEXCOM G7 GSS (161), TZIELD, Qelbree, Jornay PM, Wegovy, MOUNJARO, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
